Results 31 to 40 of about 12,044 (250)
Ocular myasthenia: A protean disorder
Survey of Ophthalmology, 1994 Ocular myasthenia is a localized form of myasthenia clinically involving only the extraocular, levator palpebrae superioris, and/or orbicularis oculi muscles. Ocular manifestations can masquerade as a variety of ocular motility disorders, including cranial nerve and gaze palsies.
D A, Weinberg, R L, Lesser, T L, Vollmer
openaire +2 more sources
Frontiers in Neurology, 2018 Bilateral cavernous carotid aneurysms (CCAs) represent a rare medical condition that can mimic other disorders. We present a rare case of bilateral CCAs simulating an ocular myasthenia.
Delia Gagliardi +12 more
doaj +1 more source
Class A drug abuse: an ophthalmologist's problem? [PDF]
, 2005 [First Paragraph] The 2002/3 British Crime Survey reported that 3% of all 16 to 59 year olds (equating to around one million people) had used a class A drug in the last year.
Firth, A.Y.
core +1 more source
Early onset bilateral juvenile myasthenia gravis masquerading as simple congenital ptosis
GMS Ophthalmology Cases, 2017 Myasthenia gravis is an autoimmune disorder affecting the neuromuscular junction. Ocular myasthenia gravis presents as ptosis with extraocular motility restriction and is prone to be misdiagnosed as third nerve palsy or congenital or aponeurotic ptosis ...
Alam, Md. Shahid, Devi Nivean, Pratheeba
doaj +1 more source
risk factors and impact on quality of life [PDF]
, 2016 Objectives Emerging evidence suggests that fatigue in myasthenia gravis (MG) is a relevant problem that negatively impacts activities of daily living (ADL). The relationship between fatigue and quality of life (QoL) has never been systematically explored
Grittner, Ulrike +5 more
core +1 more source
Diplopia in a patient presenting with “blurred vision”: a case report
Journal of Medical Case Reports, 2023 Background Myasthenia gravis is an autoimmune condition affecting the neuromuscular junction and causing muscle weakness along with fatigue (myasthenia).
Anil Harrison +3 more
doaj +1 more source
BMC Neurology, 2020 Background Ocular myasthenia gravis and Graves’ ophthalmopathy are autoimmune diseases that are mediated by membrane receptors and share many identical clinical processes.
Jingqun Tang, Chao Qin
doaj +1 more source
Myasthenia gravis with ocular symptoms following a ChAdOx1 nCoV-19 vaccination: A case report
American Journal of Ophthalmology Case Reports, 2022 Purpose: We report on the case of a 35-year-old man who developed myasthenia gravis with ocular symptoms following a ChAdOx1 nCoV-19 vaccine injection. Observations: A 35-year-old man complained of binocular diplopia one month following ChAdOx1 nCoV-19 ...
Min Chae Kang +3 more
doaj +1 more source
Ocular myasthenia gravis: A review
Indian Journal of Ophthalmology, 2014 Myasthenia gravis (MG) is a disease that affects the neuro-muscular junction resulting in classical symptoms of variable muscle weakness and fatigability. It is called the great masquerader owing to its varied clinical presentations.
Akshay Gopinathan Nair +3 more
doaj +1 more source
Pediatric ocular myasthenia gravis: Case report and literature review
The Pan-American Journal of Ophthalmology, 2019 Objective: The objective was to describe a case of ocular myasthenia gravis (MG) in a pediatric patient. Design: This is a descriptive, retrospective study and case report.
Adriana Solano +3 more
doaj +1 more source